Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

IF 14.7 1区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

Nature Communications Pub Date : 2024-03-22 DOI:10.1038/s41467-024-46805-8

Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, E Fabian Cardozo-Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martin Casapia, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti

引用次数: 0

查看原文本刊更多论文

作者更正：在抗体介导的预防试验中，高单克隆中和滴度降低了突破性 HIV-1 病毒载量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Communications Biological Science Disciplines-

CiteScore

24.90

自引率

2.40%

发文量

6928

审稿时长

3.7 months

期刊介绍： Nature Communications, an open-access journal, publishes high-quality research spanning all areas of the natural sciences. Papers featured in the journal showcase significant advances relevant to specialists in each respective field. With a 2-year impact factor of 16.6 (2022) and a median time of 8 days from submission to the first editorial decision, Nature Communications is committed to rapid dissemination of research findings. As a multidisciplinary journal, it welcomes contributions from biological, health, physical, chemical, Earth, social, mathematical, applied, and engineering sciences, aiming to highlight important breakthroughs within each domain.